Biological Sex Tests in Olympics: The IOC's New Gene Screening Policy and Why the Science Is Messier Than the Headlines

Author: Ashwin Alsi Category: Science Date: March 27, 2026

TL;DR: The IOC just mandated a one-time SRY gene test to determine who competes in women's events at the 2028 LA Olympics and beyond. It sounds clean and scientific, but the history of sex testing in sport is littered with ruined careers and flawed logic. The real question isn't whether fairness matters. It's whether a single gene can deliver it.

What the IOC Actually Announced

On March 26, 2026, the IOC Executive Board approved a new policy limiting eligibility for all female category events at the Olympics to biological females, determined by screening for the SRY gene. Every athlete entering a women's event will need to take this test once: a cheek swab, saliva sample, or blood draw. Screen negative, and you are cleared for life. Screen positive, and you are out of women's events, though you can still compete in men's or open categories.

IOC President Kirsty Coventry put it bluntly: "At the Olympic Games, even the smallest margins can be the difference between victory and defeat. So, it is absolutely clear that it would not be fair for biological males to compete in the female category."

The policy applies from the 2028 Los Angeles Games onward. It is not retroactive. It does not touch grassroots or recreational sport. And there is a narrow exception for athletes with Complete Androgen Insensitivity Syndrome (CAIS) or other rare differences in sex development where testosterone does not actually confer an advantage.

This is the product of an 18-month consultation running from September 2024 to March 2026, involving a scientific working group, legal reviews, and a survey of over 1,100 athletes. The IOC found "strong consensus" among female athletes in favor of biological sex-based eligibility.

One gene. One test. Done. Sounds straightforward. But biology has a persistent habit of being more stubborn than policy.

What Is the SRY Gene, in Plain English?

Think of the SRY gene as a biological switch. It sits on the Y chromosome and, during fetal development, it flips on the process that builds male reproductive anatomy. Most importantly, it triggers the formation of testes, which then flood the developing body with testosterone. Without the SRY gene doing its thing, the default developmental path is female.

The IOC's logic follows from there: if you have the SRY gene, your body went through male sex development, you had exposure to higher testosterone during puberty, and that gave you structural advantages in bone density, muscle mass, and lung capacity that persist even after testosterone is suppressed.

It is a reasonable chain of reasoning. It is also incomplete.

The SRY gene is not a perfect proxy for athletic advantage. A person with CAIS has the SRY gene and a Y chromosome, but their body cannot respond to testosterone at all. Their cells ignore the hormone. They develop female anatomy, go through female puberty, and gain no performance benefit whatsoever. The IOC acknowledges this with its CAIS exception. But CAIS is only one of many ways sex development can diverge from the textbook binary.

A 2000 commentary in JAMA noted that genetic sex tests can produce unfair results due to both false positives and false negatives. Andrew Sinclair, the scientist who discovered the SRY gene in 1990, has publicly opposed using his discovery to determine biological sex for sport eligibility. When the person who found the gene says it should not be used this way, that is worth pausing on.

The Ugly History of Sex Testing at the Olympics

Before evaluating where we are, it helps to see where we have been. The history of sex verification in sport is not a proud chapter.

The Nude Parades

In the 1960s, female athletes were subjected to what officials called "visual inspections." In practice, this meant lining up naked in front of doctors who would confirm, by looking, that they were women. Cold War paranoia about Eastern Bloc nations sending men disguised as women had reached a fever pitch. The solution was humiliation dressed up as protocol.

Formal sex verification began in 1966 at the Asian Games and British Empire Games. By 1968, the IOC introduced the Barr body test, a cheek swab checking for two X chromosomes. It was supposed to be more dignified. It was also scientifically crude.

Ewa Klobukowska: The First Casualty

Polish sprinter and Olympic gold medalist Ewa Klobukowska failed the new chromosomal test in 1967. She was missing an X chromosome due to a genetic disorder. She was not intersex. She was not male. She was a woman with a chromosomal anomaly that had absolutely nothing to do with athletic advantage.

Her records were stripped. Her career was destroyed. She later gave birth to a son, which should have settled any question about her sex. But by then the damage was irreversible. Klobukowska's case is the template for everything that followed: a test too blunt to capture biological reality, wielded against an athlete who lacked the power to fight back.

Martinez-Patino Fights Back

In 1985, Spanish hurdler Maria Jose Martinez-Patino failed a sex verification test. She had androgen insensitivity syndrome. Her body produced testosterone but could not use it. She was, by every functional measure, female. But the test said otherwise, and she was publicly outed, banned from competition, and stripped of her scholarship.

Martinez-Patino fought for three years. She was eventually reinstated. Her case became one of the strongest arguments against compulsory sex testing and contributed directly to the IOC's decision to move away from mandatory verification after the 1996 Atlanta Games.

The 1999 Reversal

In 1992, the IOC replaced the Barr body test with SRY and DYZ1 PCR studies. But the problems persisted. By 1999, the IOC officially discontinued universal sex verification, concluding it was "scientifically inaccurate and ethically unjustifiable."

That phrase deserves emphasis. The IOC itself, 27 years ago, called sex testing scientifically inaccurate and ethically unjustifiable. Various medical organizations, including the American Medical Association and the World Medical Association, had been advocating for abolition since 1986. The UN High Commissioner for Human Rights and UN Women later added their voices to the same position.

And now the test is back. Different gene, same fundamental problem.

Caster Semenya and Dutee Chand: The Human Cost

No conversation about sex testing in sport is complete without these two athletes. Their stories illustrate the real-world consequences of policies built on biological shortcuts.

Caster Semenya

After Semenya's dominant win at the 2009 World Championships, she was subjected to sex verification testing. The South African middle-distance runner was cleared to compete in 2010. But in 2018, World Athletics (then the IAAF) introduced new testosterone regulations, lowering the permitted level from 10 nmol/L to 5 nmol/L for events between 400m and the mile. Semenya, who has a DSD condition producing naturally elevated testosterone, was effectively barred from her best events.

She appealed to the Court of Arbitration for Sport. She lost. The CAS ruling acknowledged that the regulations were discriminatory but concluded the discrimination was "necessary, reasonable, and proportionate" to protect fair competition.

Semenya has been vocal about the new IOC policy, calling the return of genetic screening a step backward: "Reintroducing genetic screening is not progress; it is walking backward."

Other athletes affected by similar rules include Francine Niyonsaba of Burundi and Christine Mboma of Namibia. The pattern is hard to ignore. The athletes who bear the heaviest burden of these policies tend to be Black women from the Global South.

Dutee Chand

India's Dutee Chand was dropped from the 2014 Commonwealth Games after being flagged for hyperandrogenism, meaning her body naturally produced testosterone at levels higher than the permitted threshold. She was 18 years old. A sprinter from rural Odisha, she had overcome enormous odds just to reach the national team. Then a hormone test took it all away.

Chand fought back. With support from the Indian government, she took her case to CAS. In a landmark July 2015 decision, the court suspended the IAAF's hyperandrogenism regulations, finding insufficient evidence that naturally elevated testosterone directly translates to a proportional competitive advantage.

Chand's case was pivotal. The CAS ruling did not say testosterone is irrelevant. It said the IAAF had not proven its own claims to the standard required to justify excluding athletes. There is a meaningful difference between those two positions. Chand went on to compete at the 2016 and 2020 Olympics.

The Fairness Argument Is Real. So Is the Human Rights Argument.

This is where the conversation gets uncomfortable, because both sides are standing on solid ground.

The Case for the Policy

Male puberty confers measurable, lasting physical advantages. Greater bone density. Larger heart and lung capacity. More type II muscle fibers. Higher hemoglobin levels. These differences persist even after years of testosterone suppression. In elite sport, where the gap between gold and fourth place can be hundredths of a second, these margins are not trivial.

Female athletes have a right to compete on a level playing field. For decades, women fought to even have a category of their own. Protecting that category is not inherently bigoted. And the IOC's survey of 1,100 athletes found strong support for sex-based eligibility. The people most directly affected want these protections.

The Case Against

Over 70 organizations oppose the new policy, including the Sport & Rights Alliance, Human Rights Watch, Amnesty International, and ILGA World. Andrea Florence, executive director of the Sport & Rights Alliance, stated: "Gender policing and exclusion harm all women and girls, and undermine the very dignity and fairness the IOC claims to uphold."

The UN High Commissioner for Human Rights, UN Women, the American Medical Association, and the World Medical Association have all condemned sex testing in sport. These are not fringe voices.

There are practical concerns too. False positives are possible. Lab contamination from a male technician handling a sample could produce an SRY-positive result. And SRY-positive does not automatically mean an athlete had a testosterone-fueled male puberty. The gene's presence and the gene's function are different things.

Then there is the question of who this policy actually targets. Transgender women, yes. But also women with DSD conditions who have lived their entire lives as female, often without knowing they carry the SRY gene until a test tells them otherwise. For these athletes, being told they are "not female enough" is devastating.

The Political Elephant in the Room

The timing of this announcement is not coincidental. The 2028 Olympics will be held in Los Angeles, on American soil, under an administration that signed the "Keeping Men Out of Women's Sports" executive order in February 2025. The political pressure on the IOC to adopt a strict, binary framework was enormous.

That does not mean the policy is purely political. But it means we should be honest about the environment in which it was crafted. Science informed this decision. Politics shaped it.

A CAS challenge is widely expected to be filed in Lausanne. How the court balances fairness and human rights this time around will set the tone for the next decade of elite sport.

The Boxers Who Will Test the Policy

Two athletes from Paris 2024 will serve as the immediate test cases. Lin Yu-ting of Taiwan, a boxing gold medalist at the center of the gender controversy in Paris, has already passed her SRY gene test and is cleared to compete. Imane Khelif of Algeria, the other boxing gold medalist caught up in the storm, has stated she will take the test.

If both are cleared, it undercuts the narrative that Paris 2024 was somehow compromised by male athletes in women's events. If either is not cleared, the backlash will be intense and a CAS appeal virtually certain. Either way, these are real people whose lives have been reshaped by a debate most of us engage with as spectators scrolling through our feeds.

How Media Turns Complexity Into a Binary

One underappreciated dimension of this debate is how media coverage flattens the science into something unrecognizable.

The Khelif and Lin Yu-ting controversy at Paris 2024 is a textbook example. Social media and cable news reduced their stories to a single question: man or woman? That framing erases the actual biology. It erases DSD conditions. It erases the decades of medical literature showing that sex is determined by a constellation of factors, not a single gene or a single hormone level.

Indian media, which followed the Dutee Chand saga closely, tends to fall into the same trap. Coverage often frames the issue as a simple morality play: either you believe in "protecting women's sports" or you believe in "inclusion." The possibility that both values matter simultaneously, and that the tension between them requires careful, evidence-based navigation rather than sloganeering, gets lost in the rush to publish a take.

This binary framing does real harm. It makes it harder for audiences to understand why IOC biological female eligibility 2028 rules are more complicated than a cheek swab. And it makes it easier for politicians on both sides to weaponize the issue without engaging with the science underneath.

Conclusion: Precision Matters

The IOC's new SRY gene policy is an attempt to draw a bright line where biology draws a blurry one. Fairness in women's sport is a legitimate concern. Female athletes deserve clarity about who they are competing against. Nobody serious disputes that.

But a single genetic marker cannot capture the full complexity of human sex development. History has shown, repeatedly, that sex tests in sport produce collateral damage: women who are women by every lived measure, cast out by a lab result. Klobukowska. Martinez-Patino. Semenya. Chand. The list keeps growing, and the athletes on it share a common profile: women from backgrounds where resources to fight back are scarce and the stigma is crushing.

The CAIS exception in the current policy hints at the right direction, acknowledging that the gene alone is not the whole story. The question is whether that exception is broad enough to catch the full range of human variation. Given the track record, skepticism is warranted.

What we owe athletes is both fairness and dignity. Those two things are not mutually exclusive. But treating them as though they are, as though you must pick a side, has been the defining failure of sex testing in sport for over 60 years. The IOC had a chance to break that pattern. Whether it has done so, or simply repeated it with a newer test, is a question the 2028 Games will answer.

Get Our App

Biological Sex Tests in Olympics: Science vs Politics